Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Health Affairs (Project Hope)|October 7, 2024
Postapproval Innovation For Oncology Drugs And The Inflation Reduction ActHenry Grabowski, Joseph A DiMasi, Genia LongJournal of Medical Economics|April 12, 2016
Updated trends in US brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.Journal of Medical Economics|July 13, 2021
Continuing trends in U.S. brand-name and generic drug competitionHenry Grabowski, Genia Long, Richard Mortimer, et al.Health Affairs (Project Hope)|February 4, 2015
The roles of patents and research and development incentives in biopharmaceutical innovationHenry G Grabowski, Joseph A DiMasi, Genia LongJournal of Health Economics and Outcomes Research|February 18, 2022
Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's DiseaseAndrew Thach, Noam Kirson, Miriam L Zichlin, et al.Current Medical Research and Opinion|September 11, 2025
Retrospective claims analysis of the epidemiology and economic burden of diagnosed congenital cytomegalovirus in JapanPhilip O Buck, Debbie Goldschmidt, Annika Anderson, et al.Journal of Managed Care & Specialty Pharmacy|June 20, 2022
Direct health care costs associated with COVID-19 in the United StatesJessica K DeMartino, Elyse Swallow, Debbie Goldschmidt, et al.Health Affairs (Project Hope)|June 10, 2010
Analysis & commentary. How health care reform must bend the cost curveDavid CutlerPharmacoeconomics - Open|July 23, 2022
The Physician and Administrator-Reported Cost of Drug Utilization Management to Physician Practices: A Cross-Sectional SurveyMarie Louise Edwards, Perry T Yin, Michael Kuehn, et al.Current Medical Research and Opinion|August 23, 2024
Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's diseaseUrvi Desai, Dumingu Aparna Gomes, Julie Chandler, et al.Pageof 11